Prostate Cancer - Results from #180

Prostate magnetic resonance imaging to predict grade concordance, extra prostatic extension, and biochemical recurrence after radical prostatectomy. March 17, 2025

Learning From Evidence: Changes in Real-World Use of Second Androgen Receptor Targeted Treatments in Metastatic Castration-Resistant Prostate Cancer (mCRPC). March 17, 2025

Current androgen receptor antagonists under investigation for resistant prostate cancer: progress and challenges. March 17, 2025

Cancer-control outcomes with [177Lu]Lu-PSMA Radioligand Therapy in elderly, frail or comorbid mCRPC patients. March 17, 2025

LSD1+8a is an RNA biomarker of neuroendocrine prostate cancer. March 17, 2025

On-table monitoring of prostate MRI could enable tailored utilisation of gadolinium contrast. March 17, 2025

Comparing and Combining Artificial Intelligence and Spectral/Statistical Approaches for Elevating Prostate Cancer Assessment in a Biparametric MRI: A Pilot Study. March 14, 2025

T-cell Engagers in Prostate Cancer. March 14, 2025

Cyclin-Dependent Kinase Inhibition in Prostate Cancer: Past, Present, and Future. March 14, 2025

Use of biochemical and imaging criteria for selecting patients for prostate biopsy in recurrence risk assessment post-HIFU therapy. March 14, 2025

A cost-effectiveness study of PSMA-PET/CT for the detection of clinically significant prostate cancer. March 14, 2025

Nomogram predicting the outcome of salvage radiation therapy for prostate-specific antigen failure following radical prostatectomy: an exploratory analysis of a randomized, multicenter, open-label, phase 3 trial (JCOG0401). March 13, 2025

Impact of prostate cancer screening in European ancestry un-affected men with germline DNA repair pathogenic variants. March 13, 2025

Prostate dose escalation may positively impact survival in patients with clinically node-positive prostate cancer definitively treated by radiotherapy: surveillance study of the Japanese Radiation Oncology Study Group (JROSG). March 13, 2025

Role of PSMA PET/CT in imaging and management of prostate cancer. March 13, 2025

Safety and efficacy of genomic biomarker-guided neoadjuvant therapy for locally advanced and oligometastatic prostate cancer (SEGNO): study protocol for an open-label prospective phase II umbrella clinical trial. March 13, 2025

Managing elderly patients with dual metastatic cancers-navigating diagnostic and treatment challenges. March 13, 2025

Rare pathogenic structural variants show potential to enhance prostate cancer germline testing for African men. March 12, 2025

Cirrhosis and liver disease vs. adverse in-hospital outcomes after radical prostatectomy. March 12, 2025

An overview of utilizing artificial intelligence in localized prostate cancer imaging. March 12, 2025

Page 10 of 1473